Page last updated: 2024-09-05

sb 203580 and xylazine

sb 203580 has been researched along with xylazine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(xylazine)
Trials
(xylazine)
Recent Studies (post-2010) (xylazine)
3,48941,1371,981207526

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hossain, M; Liu, L; Xu, N1

Other Studies

1 other study(ies) available for sb 203580 and xylazine

ArticleYear
Pharmacological inhibition of p38 mitogen-activated protein kinases affects KC/CXCL1-induced intraluminal crawling, transendothelial migration, and chemotaxis of neutrophils in vivo.
    Mediators of inflammation, 2013, Volume: 2013

    Topics: Animals; Cells, Cultured; Chemokine CXCL1; Chemotaxis, Leukocyte; Enzyme Inhibitors; Imidazoles; Ketamine; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; p38 Mitogen-Activated Protein Kinases; Pyridines; Transendothelial and Transepithelial Migration; Xylazine

2013